March 21, 2020
From the event website:
We find ourselves at a fascinating time – pushing the envelope on psychiatric treatments, including psychedelic-assisted psychotherapy, rapid-acting agents, and more. As we move forward, this conference emphasizes the need for high-quality research, scientific/empirical evidence, and safeguards against adverse effects and outcomes. Additionally, we need the scholarly efforts of all relevant fields and interprofessional collaborations. This CME activity will cover emerging treatment areas in psychiatry including the related basic science, benefits, risks and clinical trial evidence.
If you have any questions, contact debaube@stanford.edu.
For more information, visit the event website.
